As the global economy mends, the 2021 growth of Human Fibrinogen will have significant change from previous year. According to our (LP Information) latest study, the global Human Fibrinogen market size is USD million in 2022 from USD 778.5 million in 2021, with a change of % between 2021 and 2022. The global Human Fibrinogen market size will reach USD 2210.7 million in 2028, growing at a CAGR of 16.1% over the analysis period.
The United States Human Fibrinogen market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Fibrinogen market, reaching US$ million by the year 2028. As for the Europe Human Fibrinogen landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Fibrinogen players cover CSL Behring, LFB Group, Shanghai RAAS Blood Products, and Jiangxi Boya Bio-Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Fibrinogen market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Congenital Fibrinogen Deficiency
Surgical Procedures
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma